findmyKOL

Kalkidan Bishu, MD

Basic profile

Essentia Health

ORCIDNone on fileNPI
RegionDuluth, MN · MidwestSpecialtyInterventional CardiologyFocusCardiology
Last active 2024findmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2022Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Kalkidan Bishu is a Cardiology physician affiliated with Essentia Health. OpenAlex indexes 43 publications with 1,429 citations (h-index 18).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
43publications

Distinct works indexed by OpenAlex.

1,429citations

Total citations across indexed works.

18h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
6companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

400 E 3rd St
Duluth, MN 558051951

Telephone

218-786-8364

Provider last certified this registry record 29 Jun 2020.

View the NPPES registry record

Industry payments

6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    79.8%
    Beta blocker16.9%
    Metoprolol Succinate54%Metoprolol Tartrate32%Carvedilol12%Sotalol2%
    Part D<11 patients
    Statin15.2%
    Atorvastatin Calcium69%Rosuvastatin Calcium27%Simvastatin4%
    Part D<11 patients

    + 14 more classes in this area

  • Blood & clotting

    13.7%
    Factor Xa inhibitor8%
    Eliquis69%Xarelto31%
    Part D45 patients
    P2Y12 inhibitor5.7%
    Clopidogrel86%Brilinta8%Prasugrel Hcl6%
    Part D<11 patients
  • Metabolism & gastrointestinal

    4.3%
    Potassium supplement2.1%
    Potassium Chloride100%
    Part D25 patients
    SGLT2 inhibitor1.3%
    Jardiance100%
    Part D13 patients

    + 2 more classes in this area

Where care is delivered (Part B)99.3% facility · 0.7% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”